Osteoclast growth regulatory factor
CA 2113828 A1 · Owner: Osteosa Inc. · Inventors: Yoneda, Toshiyuka; Burgess, Wilson H.; Mundy, Gregory R.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to a novel osteoclast growth regulatory factor, hereinafter referred to as "osteoclastpoietic factor (OPF)", which stimulates the formation of osteoclast bone cells a process of preparing same, therapeutic and diagnostic uses thereof, antibodies to and antagonists of OPF and assays for OPF, all of which relate to the development of therapeutics for the prevention and treatment of diseases involving bone tissue for, example, osteoporosis, paget's disease and osteopetrosis.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 23, 1992. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 23, 2012.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 23, 2014.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.